Skip to main content

JN van den Anker

First name:
JN
Last name:
van den Anker
Lambrechtse, P. ., Ziesenitz, V. ., Cohen, A. ., van den Anker, J. ., & Bos, E. . (2018). How reliable are commercially available trackers in detecting daytime sleep. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.13475 (Original work published 2018)
Vaughns, J. ., Conklin, L. ., Long, Y. ., Zheng, P. ., Faruque, F. ., Green, D. ., … Burckart, G. . (2018). Obesity and Pediatric Drug Development. Journal of Clinical Pharmacology. https://doi.org/10.1002/jcph.1054 (Original work published 2018)
van den Anker, J. ., & Allegaert, K. . (2016). Evidence-Based Use of α-2 Agonists for Sedation in the PICU: From Fiction to Facts?. Pediatric Critical Care Medicine : A Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 17(2), 182-3. https://doi.org/10.1097/PCC.0000000000000606
Williams, E. ., Vaughns, J. ., Mackey, E. ., Muret, J. ., Nadler, E. ., & van den Anker, J. . (2020). Implications of Perioperative Polypharmacy in Adolescents Undergoing Bariatric Surgery: a Single-Center Experience. Obesity Surgery, 30(7), 2832-2835. https://doi.org/10.1007/s11695-020-04456-w